Florida Medicaid and Addiction Treatment Coverage

Florida Medicaid delivers addiction treatment through managed care plans contracted under the Statewide Medicaid Managed Care program, not through traditional fee-for-service Medicaid. The Agency for Health Care Administration contracts with managed care organizations in 11 SMMC regions across Florida. Each managed care plan maintains a network of licensed substance abuse treatment providers and manages utilization through prior authorization.

The major managed care plans offering Medicaid behavioral health coverage in Florida include:

• Aetna Better Health of Florida -- operates in Regions 2 through 11
• Molina Healthcare of Florida -- operates in Regions 3, 6, 7, 8, 9, 10, and 11
• Humana Medical Plan -- operates in Regions 3, 5, 7, 9, 10, and 11
• Simply Healthcare Plans (Anthem) -- operates in Regions 7, 9, 10, and 11
• Sunshine Health (Centene) -- operates statewide in all 11 regions

Medicaid beneficiaries in Florida choose a managed care plan during open enrollment or within 30 days of Medicaid eligibility determination. Each plan contracts with different substance abuse treatment providers, making provider network verification essential before beginning treatment.

Florida Medicaid covers 8 categories of substance use disorder treatment services under the SMMC Managed Medical Assistance program: detoxification, crisis stabilization, residential treatment, partial hospitalization (PHP), intensive outpatient (IOP), outpatient individual and group therapy, medication-assisted treatment (MAT), and case management.

Residential treatment through Florida Medicaid is limited to facilities licensed by DCF under Florida Statute 397. Florida Medicaid does not cover long-term residential treatment exceeding 90 days without documented medical necessity and additional prior authorization review.

Florida Medicaid managed care plans require prior authorization for residential treatment, PHP, IOP, and extended outpatient services. The managed care plan's utilization management department reviews clinical documentation using the American Society of Addiction Medicine (ASAM) criteria to determine medical necessity and appropriate level of care.

The prior authorization process for substance abuse treatment under Florida Medicaid follows these requirements:

• Emergency detoxification services can begin before prior authorization, with retrospective review within 24 hours of admission
• Residential treatment requires prior authorization before admission, with continued stay reviews every 7 to 14 days depending on the managed care plan
• PHP authorization is granted in 2-week increments, requiring clinical documentation of ongoing medical necessity
• IOP authorization is granted in 4-week increments in most managed care plans
• Outpatient individual therapy does not require prior authorization for the first 12 sessions in most Florida Medicaid managed care plans

Denial of prior authorization by a Florida Medicaid managed care plan can be appealed through the plan's internal grievance process. Florida Statute 409.285 provides Medicaid beneficiaries the right to a fair hearing through the Agency for Health Care Administration if the managed care plan upholds the denial on internal appeal.

Florida Medicaid covers 3 FDA-approved medications for opioid use disorder: buprenorphine (Suboxone), methadone, and naltrexone (Vivitrol). Florida Medicaid also covers acamprosate and disulfiram for alcohol use disorder. Coverage for medication-assisted treatment (MAT) is mandated under the SUPPORT for Patients and Communities Act of 2018 and Florida Statute 409.906.

Specific Florida Medicaid MAT coverage details:

• Buprenorphine/naloxone (Suboxone): covered as a preferred drug in most managed care plan formularies; generic buprenorphine/naloxone film is preferred over brand-name Suboxone in Sunshine Health and Molina plans
• Methadone: covered for opioid use disorder only through SAMHSA-certified Opioid Treatment Programs (OTPs); Florida has 82 certified OTPs as of 2024
• Naltrexone injection (Vivitrol): covered with prior authorization in all Florida Medicaid managed care plans; requires documentation of opioid-free status for 7-10 days before initiation
• Naltrexone oral: covered without prior authorization for alcohol use disorder

Florida Medicaid reimburses prescribers for office-based buprenorphine treatment through the standard Medicaid evaluation and management code billing structure. Prescribers must hold a valid DEA X-waiver or meet the requirements under the Mainstreaming Addiction Treatment Act of 2023, which eliminated the separate X-waiver requirement.

Florida Medicaid eligibility for adults is limited to specific categories because Florida has not expanded Medicaid under the Affordable Care Act. Florida remains one of 10 states that have not adopted Medicaid expansion as of 2024. Standard Florida Medicaid eligibility categories that cover addiction treatment include:

• Pregnant individuals: income up to 191% of the Federal Poverty Level ($29,974 per year for a single person in 2024)
• Parents/caretaker relatives: income up to 34% of the Federal Poverty Level ($5,334 per year for a single person in 2024)
• SSI recipients: individuals receiving Supplemental Security Income automatically qualify for Florida Medicaid
• Aged, blind, or disabled: income up to 88% of the Federal Poverty Level
• Children under 19: income up to 210% of the Federal Poverty Level under Florida KidCare/Medicaid

Non-disabled, non-pregnant adults without dependent children do not qualify for Florida Medicaid regardless of income. The coverage gap in Florida affects an estimated 764,000 adults who earn too much for Medicaid but too little for Marketplace subsidies, according to the Kaiser Family Foundation. Many individuals in the coverage gap who have substance use disorders rely on DCF-funded treatment through managing entities or sliding-scale programs.

Florida Medicaid eligibility can be verified online through the ACCESS Florida system at myflfamilies.com, by calling the Florida Medicaid hotline at 1-888-367-6554, or by visiting a local DCF office. The ACCESS system provides real-time eligibility verification including the enrollee's managed care plan assignment and coverage effective dates.

Steps to verify Florida Medicaid coverage for addiction treatment:

1. Confirm active Medicaid eligibility through ACCESS Florida or the Medicaid hotline
2. Identify the assigned managed care plan listed on the Medicaid card or through ACCESS
3. Contact the managed care plan's behavioral health department to verify substance abuse treatment benefits
4. Request the plan's provider directory to identify in-network addiction treatment facilities
5. Contact the treatment provider directly to confirm Medicaid acceptance and obtain prior authorization

Treatment providers can verify Florida Medicaid eligibility through the AHCA Provider Portal or the Availity clearinghouse system. Florida Medicaid eligibility changes can occur monthly, and providers verify eligibility on the date of service to confirm active coverage.

Florida Medicaid imposes limitations on addiction treatment including the IMD exclusion, service duration caps, and narrow adult eligibility criteria. The Institutions for Mental Diseases (IMD) exclusion under federal Medicaid law prohibits federal Medicaid matching funds for residential treatment in facilities with more than 16 beds for beneficiaries aged 21 to 64. Florida received an IMD exclusion waiver in 2019 under the Section 1115 demonstration waiver, allowing limited coverage of residential treatment in larger facilities for substance use disorder.

Key Florida Medicaid addiction treatment limitations:

• Residential treatment coverage is limited to 90 days per episode without additional medical necessity documentation
• The IMD exclusion waiver limits residential SUD treatment to 30 days per qualifying admission in facilities with 17 or more beds
• Non-expansion status excludes an estimated 764,000 low-income adults from Medicaid eligibility
• Managed care plan networks vary significantly by region, with rural areas having fewer in-network treatment providers
• Prior authorization denials and delays create gaps between levels of care during step-down transitions

Florida's Section 1115 waiver is approved through 2029 and includes provisions for expanding substance use disorder treatment access. The waiver requires Florida to maintain a state-funded safety net for individuals who do not qualify for Medicaid through the DCF managing entity system, which allocates $487 million annually in state and federal block grant funds for substance abuse and mental health services.